低危骨髓增生异常综合征患者的异基因造血干细胞移植：代表欧洲血液与骨髓移植协会慢性恶性肿瘤工作组的一项回顾性分析 - Suppr | 超能文献

相似文献

1

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.低危骨髓增生异常综合征患者的异基因造血干细胞移植：代表欧洲血液与骨髓移植协会慢性恶性肿瘤工作组的一项回顾性分析

Bone Marrow Transplant. 2017 Jul;52(7):1081. doi: 10.1038/bmt.2017.86.

2

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.低危骨髓增生异常综合征患者的异基因造血干细胞移植：代表欧洲血液与骨髓移植协会慢性恶性肿瘤工作组的一项回顾性分析

Bone Marrow Transplant. 2017 Feb;52(2):209-215. doi: 10.1038/bmt.2016.266. Epub 2016 Nov 7.

3

Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.非典型慢性髓性白血病患者的异基因干细胞移植：欧洲血液与骨髓移植协会慢性恶性肿瘤工作组的一项回顾性研究

Br J Haematol. 2017 Jun;177(5):759-765. doi: 10.1111/bjh.14619. Epub 2017 Mar 28.

4

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party.在接受异基因造血干细胞移植的骨髓增生异常综合征/转化急性髓系白血病患者中验证修订后的 IPSS 在移植时的准确性：EBMT 慢性恶性肿瘤工作组的回顾性分析。

Bone Marrow Transplant. 2017 Nov;52(11):1519-1525. doi: 10.1038/bmt.2017.171. Epub 2017 Sep 11.

5

Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.原发性小儿再生障碍性贫血中前期无关供者及匹配同胞干细胞移植的相似结局。一项代表欧洲血液与骨髓移植协会英国儿科骨髓移植工作组、儿科疾病工作组及重型再生障碍性贫血工作组开展的研究。

Br J Haematol. 2015 Nov;171(4):585-94. doi: 10.1111/bjh.13614. Epub 2015 Jul 28.

6

Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.在骨髓增生异常综合征患者中，将来自人类白细胞抗原（HLA）相合同胞的骨髓移植作为一线治疗：早期移植与改善的预后相关。欧洲血液和骨髓移植组慢性白血病工作组。

Bone Marrow Transplant. 1998 Feb;21(3):255-61. doi: 10.1038/sj.bmt.1701084.

7

Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT.年龄≥70岁的骨髓增生异常综合征患者的异基因干细胞移植：欧洲血液与骨髓移植协会慢性恶性肿瘤工作组骨髓增生异常综合征小组委员会的一项回顾性研究

Biol Blood Marrow Transplant. 2017 Jan;23(1):44-52. doi: 10.1016/j.bbmt.2016.09.027. Epub 2016 Oct 5.

8

Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party.减低强度预处理方案后无关脐血与外周血干细胞移植治疗成人骨髓增生异常综合征的比较：欧洲脐血库（欧洲血液与骨髓移植协会细胞治疗与免疫生物学工作组脐血委员会）与慢性恶性肿瘤工作组的一项合作研究

Biol Blood Marrow Transplant. 2015 Mar;21(3):489-95. doi: 10.1016/j.bbmt.2014.11.675. Epub 2014 Dec 19.

9

Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants.接受异基因造血干细胞移植的慢性髓性白血病（CML）患者的EBMT风险评分的验证与扩展

Br J Haematol. 2004 Jun;125(5):613-20. doi: 10.1111/j.1365-2141.2004.04955.x.

10

Outcome of allogeneic stem cell transplantation for patients transformed to myelodysplastic syndrome or leukemia from severe aplastic anemia: a report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.严重再生障碍性贫血转化为骨髓增生异常综合征或白血病患者的异基因干细胞移植结局：欧洲血液与骨髓移植组慢性恶性肿瘤工作组MDS小组委员会及严重再生障碍性贫血工作组的报告

Biol Blood Marrow Transplant. 2014 Sep;20(9):1448-50. doi: 10.1016/j.bbmt.2014.05.028. Epub 2014 Jun 6.

引用本文的文献

1

Lower-risk myelodysplastic syndromes: Current treatment options for anemia.低危骨髓增生异常综合征：贫血的当前治疗选择

EJHaem. 2022 Aug 12;3(4):1091-1099. doi: 10.1002/jha2.523. eCollection 2022 Nov.

2

BMT for Myelodysplastic Syndrome: When and Where and How.骨髓增生异常综合征的骨髓移植：时机、地点与方式

Front Oncol. 2022 Jan 6;11:771614. doi: 10.3389/fonc.2021.771614. eCollection 2021.

3

Lower risk but high risk.低风险但高风险。